Test Price
2,800 AED✅ Home Collection Available
CNTNAP4 Gene Neurodevelopmental Disorder NGS Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2022 Accredited Processing (CAP & ISO 9001:2015 Certified).
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by expert genetic counsellors.
- ✓Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The CNTNAP4 Gene Neurodevelopmental Disorder NGS Test screens the entire coding sequence of the CNTNAP4 gene for pathogenic variants linked to autism spectrum disorder, intellectual disability, and other neurodevelopmental conditions. Employing high‑coverage Next‑Generation Sequencing (NGS), this advanced molecular assay delivers unparalleled resolution and analytical sensitivity for detecting single nucleotide variants, small indels, and copy number abnormalities.
| Feature | Our Test (CNTNAP4 NGS) | Closest Alternative (Standard Microarray) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; single‑base resolution | Limited to known copy‑number variations; misses point mutations |
| Methodology | Next‑Generation Sequencing (Illumina® platform) | Chromosomal Microarray (CMA) |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Price (UAE) | 2800 AED | 2500 – 2800 AED |
Physician Insight & Safety Protocols
“I recognise the deep anxiety families experience when seeking answers for a child’s developmental differences. This highly sensitive CNTNAP4 NGS analysis uncovers variants invisible to older methods, enabling truly individualised care plans. Please remember that genetic findings must always be correlated with a full clinical evaluation by a qualified neurologist or clinical geneticist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
Advisory: Genetic Counseling Requirement
This test provides information that should be interpreted only in the context of a detailed clinical history and family pedigree. A pre‑test and post‑test genetic counseling session is strongly recommended to ensure proper understanding and decision‑making.
Exclusion Criteria & Emergency Red Flags
- Home collection is NOT suitable if the patient is experiencing an acute neurological emergency (e.g., prolonged seizures, loss of consciousness, acute paralysis). Call 998 or proceed to the nearest Emergency Department immediately.
- This genetic test cannot be performed on patients with severe anemia or coagulation disorders who cannot safely provide a blood sample.
- If the child exhibits sudden regression, inconsolable crying with fever, or difficulty breathing, seek urgent medical attention before scheduling a routine collection.
- Individuals with a history of severe adverse reaction to venipuncture must inform the phlebotomist prior to collection.
Patient FAQ & Clinical Guidance
1. What is the CNTNAP4 gene and its role in neurodevelopmental disorders?
A: The CNTNAP4 gene encodes a neurexin family protein critical for neuronal synapse formation and communication. Pathogenic variants in this gene can lead to conditions such as autism spectrum disorder and intellectual disability. A comprehensive evaluation by a clinical geneticist is essential for accurate interpretation.
2. How is the genetic test performed, and what sample is required?
A: The test requires a whole blood sample (or extracted DNA / one drop blood on FTA Card) collected by a certified phlebotomist. DNA is extracted and sequenced using Next‑Generation Sequencing (Illumina platform) to analyze the entire CNTNAP4 gene for disease‑causing variants.
3. How should I prepare for the test and ensure accurate results?
A: Provide a detailed clinical history, participate in a pre‑genetic counseling session to draw a family pedigree, and inform the team of any medications or supplements you are currently taking. Avoid any changes to medication unless advised by your physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality and encrypted storage. Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | CNTNAP4 Gene Neurodevelopmental Disorder NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card (dried blood spot) |
| Methodology Used | Next‑Generation Sequencing (Illumina® platform) |
| ICD-10-CM Code | F84.0 (Autism spectrum disorder) / F79 (Intellectual disability) |
| LOINC Code | 81245-0 (Gene mutations found in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians